Table 4.
Quantitative coronary angiographic analysis
| Parameter | BiOSS LIM® | Prolim® | Alex® | |||
|---|---|---|---|---|---|---|
| n = 11 (%) | n = 29 (%) | n = 16 (%) | ||||
| MV | MB | Mean | ||||
| Pre stenting | ||||||
| Lesion length (mm) | 15.86 ± 2.65 | 14.47 ± 1.84 | 11.75 ± 3.29 | 0.001**,*** | ||
| RVD (mm) | 3.69 ± 0.16 | 3.0 ± 0.13 | 3.35 ± 0.14 | 3.39 ± 0.24 | 2.93 ± 0.34 | p < 0.01**,*** |
| MV—%DS | 53.1 ± 9.7 | 44.8 ± 12.1 | 48.9 ± 10.9 | 64.6 ± 15.3 | 61.6 ± 11.4 | 0.0002**,**** |
| MLD (mm) | 1.73 ± 0.27 | 1.65 ± 0.14 | 1.69 ± 0.2 | 1.21 ± 0.34 | 1.11 ± 0.32 | 0.00008*,*** |
| Post stenting | ||||||
| RVD (mm) | 3.68 ± 0.19 | 3.02 ± 0.08 | 3.35 ± 0.14 | 3.41 ± 0.23 | 3.06 ± 0.4 | p < 0.01**,*** |
| MV—%DS | 9.4 ± 4.3 | 8.8 ± 3.4 | 9.1 ± 7.7 | 9.6 ± 4.1 | 5.31 ± 4.33 | 0.02** |
| MLD (mm) | 3.33 ± 0.17 | 2.75 ± 0.1 | 3.04 ± 0.14 | 3.08 ± 0.28 | 2.89 ± 0.4 | 0.03** |
| ALG (mm) | 1.6 ± 0.3 | 1.1 ± 0.16 | 1.35 ± 0.23 | 1.86 ± 0.39 | 1.78 ± 0.47 | 0.001*,*** |
| Follow-up | ||||||
| RVD (mm) | 3.63 ± 0.25 | 2.96 ± 0.09 | 3.29 ± 0.17 | 3.45 ± 0.25 | 2.98 ± 0.45 | p < 0.01**,*** |
| MV—%DS | 18.2 ± 4.3 | 20.3 ± 7.4 | 19.3 ± 11.7 | 18.3 ± 6 | 12.69 ± 17.99 | p = 0.08 |
| MLD (mm) | 2.97 ± 0.25 | 2.36 ± 0.22 | 2.67 ± 0.23 | 2.82 ± 0.37 | 2.61 ± 0.69 | p = 0.03** |
| LLL (mm) | 0.36 ± 0.25 | 0.39 ± 0.13 | 0.38 ± 0.19 | 0.26 ± 0.17 | 0.28 ± 0.47 | p = 0.02* |
RVD reference vessel diameter, %DS % diameter stenosis, MLD minimal lumen diameter, ALG acute lumen gain, LLL late lumen loss, FU follow-up, MV main vessel, MB main branch, *p < 0.05 for Prolim vs. BiOSS LIM; **p < 0.05 Prolim vs. Alex; ***p < 0.05 BiOSS LIM vs. Alex